Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Colorimetric determination of gabapentin in pharmaceutical formulation.

Abdellatef HE, Khalil HM.

J Pharm Biomed Anal. 2003 Feb 5;31(1):209-14.

PMID:
12560067
2.

Sensitive and selective spectrophotometric assay of gabapentin in capsules using sodium 1, 2-naphthoquinone-4-sulfonate.

Abdulrahman SA, Basavaiah K.

Drug Test Anal. 2011 Oct;3(10):748-54. doi: 10.1002/dta.242. Epub 2011 Feb 21.

PMID:
21337720
3.

"From safe source to safe sink" development of colorimetric assay for gabapentin in bulk drug and capsules using naturally derived genipin.

Winotapun W, Kongpakwattana K, Dejpittayanunt S, Pathomcharoensukchai S, Suksaran U, Nuntharatanapong N, Rojanarata T.

Talanta. 2012 Sep 15;99:997-1003. doi: 10.1016/j.talanta.2012.07.084. Epub 2012 Aug 10.

PMID:
22967654
4.

Spectrofluorimetric determination of vigabatrin and gabapentin in urine and dosage forms through derivatization with fluorescamine.

Belal F, Abdine H, Al-Majed A, Khalil NY.

J Pharm Biomed Anal. 2002 Jan 1;27(1-2):253-60.

PMID:
11682233
5.

Development and application of a validated HPLC method for the determination of gabapentin and its major degradation impurity in drug products.

Ciavarella AB, Gupta A, Sayeed VA, Khan MA, Faustino PJ.

J Pharm Biomed Anal. 2007 Apr 11;43(5):1647-53. Epub 2007 Jan 5.

PMID:
17275240
6.

Spectrophotometric determination of gabapentin in pharmaceutical formulations using ninhydrin and pi-acceptors.

Siddiqui FA, Arayne MS, Sultana N, Qureshi F, Mirza AZ, Zuberi MH, Bahadur SS, Afridi NS, Shamshad H, Rehman N.

Eur J Med Chem. 2010 Jul;45(7):2761-7. doi: 10.1016/j.ejmech.2010.02.058. Epub 2010 Mar 7.

PMID:
20381213
7.
8.
9.

Colorimetric and fluorimetric methods for determination of panthenol in cosmetic and pharmaceutical formulation.

Shehata MA, Tawakkol SM, Abdel Fattah LE.

J Pharm Biomed Anal. 2002 Feb 1;27(5):729-35.

PMID:
11814714
10.

Development and validation of sensitive spectrophotometric method for determination of two antiepileptics in pharmaceutical formulations.

Gouda AA, Malah ZA.

Spectrochim Acta A Mol Biomol Spectrosc. 2013 Mar 15;105:488-96. doi: 10.1016/j.saa.2012.12.053. Epub 2013 Jan 2.

PMID:
23352920
11.

Determination of the antiepileptics vigabatrin and gabapentin in dosage forms and biological fluids using Hantzsch reaction.

al-Zehouri J, al-Madi S, Belal F.

Arzneimittelforschung. 2001 Feb;51(2):97-103.

PMID:
11258050
12.

Development and application of a validated HPLC method for the analysis of dissolution samples of gabapentin drug products.

Gupta A, Ciavarella AB, Sayeed VA, Khan MA, Faustino PJ.

J Pharm Biomed Anal. 2008 Jan 7;46(1):181-6. Epub 2007 Sep 1.

PMID:
17935923
13.

Automated microanalysis of gabapentin in human serum by high-performance liquid chromatography with fluorometric detection.

Tang PH, Miles MV, Glauser TA, DeGrauw T.

J Chromatogr B Biomed Sci Appl. 1999 Apr 30;727(1-2):125-9.

PMID:
10360431
14.

Spectrophotometric stability-indicating methods for the determination of leflunomide in the presence of its degradates.

Abbas SS, Bebawy LI, Fattah LA, Refaat HH.

J AOAC Int. 2006 Nov-Dec;89(6):1524-31.

PMID:
17225597
15.
16.

Novel colorimetric assay of indomethacin using 4-carboxyl-2,6-dinitrobenzene diazonium ion.

Adegoke OA, Idowu OS, Olaniyi AA.

Acta Pharm. 2006 Jun;56(2):189-202.

PMID:
16613725
17.

Procedure for the monitoring of gabapentin with 2,4,6-trinitrobenzene sulfonic acid derivatization followed by HPLC with ultraviolet detection.

Juenke JM, Brown PI, McMillin GA, Urry FM.

Clin Chem. 2003 Jul;49(7):1198-201. No abstract available.

18.

Use of pi-acceptors for spectrophotometric determination of dicyclomine hydrochloride.

Bebawy LI, Issa YM, Abdel Moneim KM.

J AOAC Int. 2003 Jan-Feb;86(1):1-7.

PMID:
12607733
19.

High-performance liquid chromatographic method for the determination of gabapentin in human plasma.

Zhu Z, Neirinck L.

J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Nov 5;779(2):307-12.

PMID:
12361744
20.

Stability indicating methods for assay of mequitazine in presence of its degradate.

El-Ragehy NA, Badawey AM, El Khateeb SZ.

J Pharm Biomed Anal. 2002 Jun 20;29(1-2):121-37.

PMID:
12062671

Supplemental Content

Support Center